Heather Bascom
Family · Medford, ORNPI 1124660154
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,252 of the $2,848 with a category attached, or 79.1%. 29 manufacturers reported payments, led by Livanova USA, Inc. at 34.8% of the total. 2025 is the largest year on record at $2,674, more than ten times the $99 reported in 2023. Among family clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $28.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$991
- UCB, Inc.$374
- AbbVie$216
- Argenx US, Inc.$205
- EMD Serono, Inc.$148
- Pfizer$86
- plus $828 from 23 others
What the payments were for
- Travel & lodging$59621%
- Food & beverage$2,25279%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 10 | $991 |
| UCB, Inc. | 15 | $374 |
| AbbVie | 13 | $216 |
| Argenx US, Inc. | 9 | $205 |
| EMD Serono, Inc. | 10 | $148 |
| Pfizer | 4 | $86 |
| Lundbeck LLC | 4 | $76 |
| TG Therapeutics, Inc. | 3 | $63 |
| Merz Pharmaceuticals, LLC | 2 | $56 |
| Lilly USA, LLC | 2 | $48 |
| Ultragenyx Pharmaceutical Inc. | 3 | $48 |
| Eisai Inc. | 2 | $46 |
| AstraZeneca | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $41 |
| Biogen | 2 | $38 |
| SK Life Science, Inc. | 2 | $36 |
| Cycle Pharmaceuticals Inc | 2 | $36 |
| CSL Behring | 1 | $35 |
| Novartis | 1 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Medline Industries LP | 1 | $23 |
| Genentech USA, Inc. | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$857
How this compares
$2,848 in reported general payments places this provider in the 95th percentile of 1,130 family providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Other family in Medford
- David ArnopoleMedford$38K
- Denise PartinMedford$7K
- Sarah RobersonMedford$4K
- Jody HaasMedford$3K
- Molly ThompsonMedford$3K
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- Heather HermanCorvallis$34K
- Amy BartramOregon City$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.